| 1 |
33980604 | Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1. | 2021 Jul |
2 |
| 2 |
32635975 | Transport of ribavirin in human myelogenous leukemia cell line K562. | 2020 Jul 1 |
5 |
| 3 |
32864162 | Pharmacogenomics of COVID-19 therapies. | 2020 |
1 |
| 4 |
30716294 | Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters. | 2019 May |
2 |
| 5 |
28207300 | Single Nucleotide rs760370 Polymorphism at the Main Ribavirin Transporter Gene Detection by PCR-RFLP Assay Compared with the TaqMan Assay and Its Relation to Sustained Virological Response in Chronic HCV Patients Treated with Pegylated Interferon-Ribavirin Therapy. | 2017 Feb |
2 |
| 6 |
28417642 | Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin. | 2017 Apr |
4 |
| 7 |
26750805 | Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients. | 2016 Aug |
1 |
| 8 |
25011570 | Contribution of CNT1 and ENT1 to ribavirin uptake in human hepatocytes. | 2015 |
12 |
| 9 |
25339775 | Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1. | 2015 Jan |
1 |
| 10 |
25583751 | SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. | 2015 Apr |
11 |
| 11 |
25661337 | Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients. | 2015 Feb |
1 |
| 12 |
25661339 | ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy. | 2015 Feb |
1 |
| 13 |
26279293 | ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors. | 2015 |
3 |
| 14 |
23459628 | Effects of dipyridamole coadministration on the pharmacokinetics of ribavirin in healthy volunteers. | 2013 |
5 |
| 15 |
22212648 | Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients. | 2012 May |
3 |
| 16 |
22232287 | ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system. | 2012 Mar |
13 |
| 17 |
21543469 | Host-based ribavirin resistance influences hepatitis C virus replication and treatment response. | 2011 Jul |
3 |
| 18 |
20096989 | Kinetic study of anti-viral ribavirin uptake mediated by hCNT3 and hENT1 in Xenopus laevis oocytes. | 2010 Mar |
1 |
| 19 |
20185188 | Characterization of ribavirin uptake systems in human hepatocytes. | 2010 Apr |
7 |
| 20 |
20812847 | Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection. | 2010 Oct 15 |
5 |
| 21 |
20814156 | Human erythrocyte nucleoside transporter ENT1 functions at ice-cold temperatures. | 2010 |
1 |
| 22 |
19164463 | The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes. | 2009 Apr |
5 |
| 23 |
19244331 | Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. | 2009 May |
8 |
| 24 |
17140564 | Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters. | 2007 Feb 14 |
2 |